27 related articles for article (PubMed ID: 38527696)
1. Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population.
Jewell JS; Bemis EA; Black JC
J Addict Med; 2024 Jun; ():. PubMed ID: 38832681
[TBL] [Abstract][Full Text] [Related]
2. Opioid-related xylazine toxicity manifesting as myonecrosis, rhabdomyolysis, multifocal ischemic cerebral infarcts, and cerebral edema.
Nwodim O; Karsalia R; Heslin ME; Lieberman AE; Wang SZ; Kalanuria AA; Elser HC; Driessen B; Caruso C; Anesi GL
J Am Coll Emerg Physicians Open; 2024 Jun; 5(3):e13187. PubMed ID: 38846102
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of adults reporting illicitly manufactured fentanyl or heroin use or prescription opioid misuse in the United States, 2019.
Jiang X; Guy GP; Dunphy C; Pickens CM; Jones CM
Drug Alcohol Depend; 2021 Dec; 229(Pt A):109160. PubMed ID: 34740067
[TBL] [Abstract][Full Text] [Related]
4. Past-Year Kratom Use in the U.S.: Estimates From a Nationally Representative Sample.
Palamar JJ
Am J Prev Med; 2021 Aug; 61(2):240-245. PubMed ID: 34027890
[TBL] [Abstract][Full Text] [Related]
5. Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids.
Cicero TJ; Ellis MS; Kasper ZA
Drug Alcohol Depend; 2017 Aug; 177():101-103. PubMed ID: 28582697
[TBL] [Abstract][Full Text] [Related]
6. Recent Use of Synthetic Cannabinoids, Synthetic Opioids, and Other Psychoactive Drug Groups among High-risk Drug Users.
Shapira B; Berkovitz R; Rosca P; Neumark Y
J Psychoactive Drugs; 2020; 52(4):334-343. PubMed ID: 32345134
[TBL] [Abstract][Full Text] [Related]
7. Changes in Opioid-Involved Overdose Deaths by Opioid Type and Presence of Benzodiazepines, Cocaine, and Methamphetamine - 25 States, July-December 2017 to January-June 2018.
Gladden RM; O'Donnell J; Mattson CL; Seth P
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(34):737-744. PubMed ID: 31465320
[TBL] [Abstract][Full Text] [Related]
8. Illicitly Manufactured Fentanyl Use Among Individuals in the U.S., 2022.
Palamar JJ
Am J Prev Med; 2024 Mar; ():. PubMed ID: 38527696
[TBL] [Abstract][Full Text] [Related]
9. The Opioid Crisis: Prevalence and Markets of Opioids.
Gardner EA; McGrath SA; Dowling D; Bai D
Forensic Sci Rev; 2022 Jan; 34(1):43-70. PubMed ID: 35105535
[TBL] [Abstract][Full Text] [Related]
10. Misuse of Novel Synthetic Opioids: A Deadly New Trend.
Prekupec MP; Mansky PA; Baumann MH
J Addict Med; 2017; 11(4):256-265. PubMed ID: 28590391
[TBL] [Abstract][Full Text] [Related]
11. The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs.
Kim HK; Connors NJ; Mazer-Amirshahi ME
Expert Opin Drug Saf; 2019 Jun; 18(6):465-475. PubMed ID: 31033357
[TBL] [Abstract][Full Text] [Related]
12. U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market.
Baumann MH; Tocco G; Papsun DM; Mohr AL; Fogarty MF; Krotulski AJ
Brain Sci; 2020 Nov; 10(11):. PubMed ID: 33238449
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
